RxDoctor Payments Data

Keith Heier, MD

Orthopaedic Surgery · Carrollton, TXNPI 1821013020

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (46.4%), royalties or licence payments and consulting fees — rather than concentrated in one kind of arrangement. Linvatec Corporation accounts for 67.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $517,525 and has fallen 85.4% since, to $75,524 in 2025. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,027,304in general payments, 2019–2025

Across 220 payments — averaging $4669.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$695K
  • In2bones USA, LLC$289K
  • 4web, Inc.$19K
  • International Life Sciences$8K
  • Theramicro, Inc.$6K
  • Restor3d, Inc.$3K
  • plus $7K from 12 others
$221,077in ownership & investment interests, 2019–2025

Across 16 payments — averaging $13,817 each. An ownership or investment interest held by the physician or an immediate family member.

  • 4web, Inc.$171K
  • Gramercy Extremity Orthopedics LLC$50K
  • In2bones USA, LLC$0

What the payments were for

  • Royalty or licence$461,26045%
  • Consulting fees$62,5206%
  • Speaking & faculty fees$5,0000%
  • Grants$5,0000%
  • Travel & lodging$8,2741%
  • Food & beverage$6,0711%
  • Education$1,9530%
  • Gifts$950%
  • Other$477,13046%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,027,304 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$163,238
Medicare patients
341
Services billed
1,892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban11$3,623
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen75$816
Ondansetron Hcl82$354
Gabapentin55$346
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$265
Tramadol Hcl38$161
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$144
Cephalexin78$119
Clindamycin Hcl15$26

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Carrollton

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →